Active Ingredient History

NOW
  • Now
Dantrolene is a drug which was approved by FDA for the treatment of chronic spasticity and malignant hyperthermia (a rare life-threatening clinical syndrome). Dantrolene effect was shown both in vivo and in vitro and proved to be mediated by interaction with Ryanodine receptor 1. The drug has a potential for hepatotoxicity and should be used as indicated in the label.   NCATS

  • SMILES: [O-][N+](=O)c1ccc(cc1)c2oc(\C=N\N3CC(=O)NC3=O)cc2
  • InChIKey: OZOMQRBLCMDCEG-VIZOYTHASA-N
  • Mol. Mass: 314.26
  • ALogP: 1.74
  • ChEMBL Molecules:
More Chemistry

Drug Pricing (per unit)

United States

$0.2572 - $7507.9500

Australia

$0.5048 - $0.8544
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

dantamacrin | dantrium | dantrolene | dantrolene sodium | dantrolene sodium salt | dantroleno | dantrolenum | f-368 | f-440

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue